These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7370100)

  • 1. [First report of experiences with interstitial radiation therapy of the prostatic carcinoma using 125-I-seeds: indication, practical performance and radioprotection (author's transl)].
    Knüfermann H; Kuphal K; Bruggmoser G; Wannenmacher M; Sinagowitz E; Sommerkamp H
    Strahlentherapie; 1980 Mar; 156(3):167-77. PubMed ID: 7370100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimizing the number of implantation needles for prostate (125)I brachytherapy: an investigation of possibilities and implications.
    Steggerda MJ; van der Poel HG; Moonen LM
    Brachytherapy; 2010; 9(4):319-27. PubMed ID: 20691644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
    Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
    Cosset JM; Pinillos-Ashton L; Mettler F;
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interstitial radiotherapy of prostatic carcinoma with 125-iodine. Radiation protection measures].
    Knüfermann H; Kuphal K; Wannenmacher M
    Strahlentherapie Sonderb; 1978; 75():213-6. PubMed ID: 555051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Measurement of the radiation load to bladder and rectum in gynecological brachytherapy with a mobile radiation source (author's transl)].
    Busch M
    Strahlentherapie; 1978 Oct; 154(10):681-5. PubMed ID: 694958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
    Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
    Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
    Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiation therapy of prostatic carcinoma (author's transl)].
    Wannenmacher M
    Strahlentherapie; 1980 Nov; 156(11):737-41. PubMed ID: 6776658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy.
    Hsu IC; Lessard E; Weinberg V; Pouliot J
    Brachytherapy; 2004; 3(3):147-52. PubMed ID: 15533807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of the radiological protection in the interstitial radiotherapy with radiogold seeds (author's transl)].
    Schmidt J
    Strahlentherapie; 1981 Jan; 157(1):29-32. PubMed ID: 7210044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative dosimetric model for formulating a semi-analytical solution for the activity-volume relationship in prostate implants.
    Lee PC; Parks EK; Moran BJ
    Med Dosim; 2003; 28(4):243-53. PubMed ID: 14684189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
    Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].
    Kaulich TW; Lamprecht U; Paulsen F; Lorenz J; Maurer U; Loeser W; Bichler KH; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2002 Dec; 178(12):667-75. PubMed ID: 12491054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects from high voltage therapy of carcinoma of the prostate (author's transl)].
    Burchardt P; Franke HD; Klosterhalfen H; Zimmer R
    Urologe A; 1973 Sep; 12(5):254-5. PubMed ID: 4202747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.